BPG is committed to discovery and dissemination of knowledge
Citation
Shi JF, Xu H, Gao JF, Wu JB. Adjuvant irinotecan-apatinib therapy for recurrent/metastatic gastric cancer after surgery: A real-world evaluation. World J Gastrointest Surg 2026; 18(3): 114569 [DOI: 10.4240/wjgs.v18.i3.114569]
Please LOGIN to submit a new comment.
Write to the Help Desk